Form 4 for ATRC AtriCure, Inc.
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001323885-24-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 | 2024-03-05 | ATRC | Dahlquist Karl S. | CLO | S - Sale | $37.36 | -8,231 | 52.8K | -13% | -$307.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 8,231 | $37.36 | 52,839 | D | — | — | (F1) These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023. (F2) This transaction was executed in multiple trades at prices ranging from $36.57 to $37.74 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |